First Time Loading...

Haemonetics Corp
NYSE:HAE

Watchlist Manager
Haemonetics Corp Logo
Haemonetics Corp
NYSE:HAE
Watchlist
Price: 95.2 USD -0.19% Market Closed
Updated: May 8, 2024
Section:
 

Relative Value

The Relative Value of one HAE stock under the Base Case scenario is 123.19 USD. Compared to the current market price of 95.2 USD, Haemonetics Corp is Undervalued by 23%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

HAE Relative Value
Base Case
123.19 USD
Undervaluation 23%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

3.8
P/S
P/S
Price to Sales
3.8
vs History
50
vs Industry
33
Median 3Y
3.5
Median 5Y
3.8
Industry
2.4
Forward
3.7
More Details
38.2
P/E
P/E
Price to Earnings
38.2
vs History
74
vs Industry
13
Median 3Y
43.4
Median 5Y
52.2
Industry
23.4
Forward
23.8
More Details
24.5
P/OCF
P/OCF
Price to OCF
24.5
vs History
55
vs Industry
17
Median 3Y
19.1
Median 5Y
26.9
Industry
15.5
More Details
21.2
P/FCFE
P/FCFE
Price to FCFE
21.2
vs History
71
vs Industry
24
Median 3Y
25.6
Median 5Y
29.4
Industry
23.2
More Details
5.1
P/B
P/B
Price to Book Value
5.1
vs History
53
vs Industry
16
Median 3Y
4.9
Median 5Y
5.3
Industry
2.3
More Details
4.3
EV/S
EV/S
Enterprise Value to Sales
4.3
vs History
49
vs Industry
28
Median 3Y
4
Median 5Y
4.3
Industry
2.5
Forward
4.2
More Details
8.1
EV/GP
EV/GP
Enterprise Value to Gross Profit
8.1
vs History
53
vs Industry
28
Median 3Y
7.6
Median 5Y
8.4
Industry
5.3
More Details
18.8
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
18.8
vs History
60
vs Industry
18
Median 3Y
18.7
Median 5Y
20.2
Industry
12.6
Forward
15.2
More Details
27.6
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
27.6
vs History
82
vs Industry
17
Median 3Y
32.8
Median 5Y
34.2
Industry
17.2
Forward
19.8
More Details
27.9
EV/OCF
EV/OCF
Enterprise Value to OCF
27.9
vs History
50
vs Industry
16
Median 3Y
21.7
Median 5Y
28
Industry
15.3
More Details
42.7
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
42.7
vs History
58
vs Industry
12
Median 3Y
41.4
Median 5Y
47.9
Industry
19.8
More Details
2.8
EV/IC
EV/IC
Enterprise Value to IC
2.8
vs History
61
vs Industry
29
Median 3Y
2.7
Median 5Y
3
Industry
2
More Details

Multiples Across Competitors

HAE Competitors Multiples
Haemonetics Corp Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Haemonetics Corp
NYSE:HAE
4.8B USD 3.8 38.2 18.8 27.6
JP
Hoya Corp
TSE:7741
6.4T JPY 8.5 38.2 23.2 28.6
CH
Alcon AG
SIX:ALC
36.1B CHF 4.2 40.9 18.2 36.9
DK
Coloplast A/S
CSE:COLO B
188.9B DKK 7.6 38.8 25.5 29.7
US
Align Technology Inc
NASDAQ:ALGN
21.6B USD 5.5 46.6 25.6 31.1
US
Cooper Companies Inc
NYSE:COO
18.6B USD 5.1 63.8 23.3 39.5
KR
HLB Inc
KOSDAQ:028300
13.5T KRW 315.1 -71.5 -116.5 -107.5
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
61.4B CNY 15.6 37.1 32.5 32.5
UK
ConvaTec Group PLC
LSE:CTEC
5.4B GBP 3.1 51.5 46.9 50.9
US
DENTSPLY SIRONA Inc
NASDAQ:XRAY
5.9B USD 1.5 -61.7 11.7 26.1
US
Lantheus Holdings Inc
NASDAQ:LNTH
5.3B USD 3.9 11.4 9.5 10.8

See Also

Summary
HAE intrinsic value, competitors valuation, and company profile.
DCF Valuation
HAE stock valuation using Discount Cash Flow valuation method.
Relative Valuation
HAE stock valuation using valuation multiples.
Wall Street Estimates
HAE price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
HAE stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 135,300+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.